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"The fundament upon which all our knowledge and learn- 
ing rests is the inexplicable. It is to this that every 
explanation, through few or many intermediate 
stages, leads". 
Arthur Schopenhauer, "Parerga and Paralipomena", 
1851 
1, Summary 
In this short review, the merits and limits of three 
theoretical concepts explaining the functional role of the 
* Corresponding author. Fax: +33 76 514218. 
0005-2728/96/$15.00 © 1996 Elsevier Science B.V. All rights reserved 
PH S0005-2728(96)00011-4  
creatine kinase system in muscle and brain cells are anal- 
ysed. In addition to the usual concept of an energy buffer 
system and the recently proposed metabolic apacity the- 
ory (Sweeney, H.L. (1994) Med. Sci. Sports Exerc. 26, 
30-36), it is proposed that coupled creatine kinase systems 
are involved in effective metabolic regulation of energy 
fluxes and oxidative phosphorylation, beside their energy 
transfer function. This aspect of the system is considered 
on the basis of metabolic ontrol analysis. It is shown by 
using the results of mathematical modelling that, due to 
amplification of ADP fluxes from the cytoplasm by the 
mechanism of metabolic hannelling, coupled mitochon- 
drial creatine kinase may exert a flux control coefficient 
significantly exceeding 1. 
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2. Introduction 
In studies of cellular bioenergetics, the complex nature 
of interactions between different cellular components and 
their influence on each other - functional coupling of 
different processes by a mechanism of metabolic chan- 
nelling, leading to the phenomenon of metabolic ompart- 
mentation - is becoming more and more obvious. This 
conforms to the understanding that to elucidate the mecha- 
nisms of cellular regulation, the complex interactions be- 
tween structural and functional units should be accounted 
for. New developments in studies of creatine kinase sys- 
tems may well illustrate this conclusion. 
The creatine kinase reaction was discovered in muscle 
extracts by Karl Lohman in 1934 in Germany [1]. This 
reaction: 
phosphocreatine + MgADP + H ~ creatine + MgATP 
is catalyzed by different isoenzymes of creatine kinase 
(CK), which are present in numerous tissues (for recent 
reviews see Refs. [2,3]) and play important roles in energy 
metabolism in heart, skeletal muscle, brain and smooth 
muscle. These isoenzymes are kinetically very similar but 
differ in their capacity to associate with subcellular or- 
ganelles or protein structures [2,3]. The CK isoenzymes, 
brain form BB, muscle form MM and two mitochondrial 
forms, sarcomeric (expressed mostly in heart and skeletal 
muscle and probably in some brain cells such as Purkinje 
neurons) and ubiquitous (expressed in many tissues) MiCK, 
are encoded by different genes, the homology between BB 
and MM being 77-82%, and that between MM or BB and 
MiCK isoenzymes 60-65% [4,5]. The phylogenetic (evolu- 
tionary) tree constructed on the basis of protein (or nucleic 
acid) sequences shows that, during evolution, a first gene 
duplication event resulted in primordial cytoplasmic and 
mitochondrial CK isoenzymes, gene duplications giving 
rise to the multiple cytoplasmic and mitochondrial isoen- 
zymes occurring at a later stage during evolution [4]. Why 
was that - the appearance of MiCK being different from 
the others - necessary? what was and still is the signifi- 
cance of this event for the cell's life? To answer these 
questions, we have to understand the functional aspect of 
the problem - what is the function of CK in the cells? 
Three possible answers to these questions can be found in 
the literature. 
2.1. Creatine kinase: energy buffer system 
It is an energy buffer function of the equilibrium crea- 
tine kinase reaction which is usually ascribed to the sys- 
tem, consisting of creatine kinase, creatine (Cr) and phos- 
phocreatine (PCr) and related to the ATP-ADP system. 
According to this concept, the enzyme simply serves the 
purpose of maintaining an adequate ATP/ADP ratio in the 
cells with increased energy demand [6,7]. Historically, this 
role was ascribed to the creatine kinase system after 
classical works by the Davies group showing that one 
observes ATP splitting in the contracting muscle cells if 
creatine kinase is inhibited [8,9]. Since that time, it has 
been assumed that ATP produced in phosphorylation reac- 
tions coupled to substrate oxidation in mitochondria or 
glycolysis freely and rapidly diffuses to all sites of its 
utilization to be used in ATPase reactions to cover all 
cellular equirements in energy. Accordingly, ADP is taken 
to diffuse rapidly back for rephosphorylation. Thus, all 
energy requirements of the cell can, according to this 
concept, be explained on the basis of the biochemistry of 
adenine nucleotides. Concerning phosphocreatine and also 
phosphoarginine (in the past both were called 'phos- 
phagens' [9]), it was assumed that they serve only as a 
store of energy, being produced via equilibrium creatine 
(or arginine) kinase reactions from ATP produced in some 
excess with respect to cellular needs of energy. These 
'energy stores' were considered to be used only in times of 
significant fluctuations in energy need to restore the neces- 
sary amount of ATP via the same equilibrium kinase 
reactions, and therefore, these compounds were also called 
temporary energy buffers. For this function, one isoen- 
zyme of creatine kinase functioning in equilibrium is 
sufficient. The basic principle of this concept is the use of 
the creatine kinase equilibrium equation. The apparent 
equilibrium constant of the CK reaction at pH 7.0, K'eq = 
[ATP] X [Cr]/[ADP] X [PCr] is 166, and if the reaction is 
close to equilibrium, the ATP/ADP ratio exceeds 100 
under physiological conditions in muscle cells [10,11]. A 
practical aspect of this concept is that it allows one to 
calculate the free cytoplasmic ADP concentration i the 
cells - around 50 p~M, which cannot be measured either 
biochemically or by NMR, and this aspect is widely 
exploited in practically all modern metabolic studies. There 
is good evidence that in the cytoplasmic ompartment of
the muscle cells creatine kinase is rather close to equilib- 
rium [12]. This compartment contains mostly creatine ki- 
nase MM isoenzyme; in fast skeletal muscle its activity is 
about 5-7-times greater than in the heart, slow skeletal 
muscle being somewhere between them [ 13-15]. Magneti- 
zation transfer studies using the phosphorus NMR tech- 
nique allowed the determination of the rate constants and 
fluxes in both direction; they were found to be equal to 
each other and to exceed the total energy flux - steady- 
state rates of ATP production, energy transfer and utiliza- 
tion - almost by an order of magnitude, the latter evi- 
dence conforming to the cytoplasmic equilibrium of crea- 
tine kinase substrates [16,17]. 
This simple and useful concept which is employed in 
most studies of cellular metabolism may help to clarify 
some events (concentration values, fluxes, etc.) in the 
cytoplasmic ompartment, nevertheless, it still does not 
provide a satisfactory explanation for the existence of 
different creatine kinase isoenzymes. It is important to note 
here again that all of them - mitochondrial isoenzyme, 
MM or BB - have very similar kinetic and thermody- 
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namic characteristics, ince they all have the same con- 
served structure of the active center [4], and in the cells the 
major difference is in their intracellular localisation [2,3]. 
The simple temporary energy buffer concept of creatine 
kinase is not sufficient o illuminate this phenomenon, and 
thus lacks an explanation for the appearance of MiCK 
during evolution. One rather mysterious argument often 
used by faithful proponents of this simple theory is that, 
since an equilibrium state in the cytoplasmic ompartment 
conforms to the buffer role of creatine kinase, it precludes 
any other approaches. 
2.2. Metabolic capacity system 
However, simple and already often complemented 
quantitative analysis of the equilibrium equation using a 
value for the equilibrium constant of 166 showed that in 
fact about 99% of the energy flux via equilibrium creatine 
kinase is represented by that of phosphocreatine via a 
mechanism of facilitated iffusion [18]. This modifies the 
concept of the simple temporary energy buffer role of 
creatine kinase into that of a metabolic apacity system 
with a new additional property - spatial buffering [18- 
20]. This theory places the equilibrium creatine kinase 
from the sidewalks onto the central pathway between 
energy production and utilization and is well illustrated by 
analogy with an electrical circuit with capacity between 
resistance (ATPases) and battery (mitochondria), and from 
this analogy the theory derived its name [19]. It takes into 
consideration the structural organization of muscle cells - 
that cytoplasmic space containing a significant amount of 
MM creatine kinase is between mitochondria nd myofib- 
rils in these cells. According to this concept, mitochondria 
release ATP into the cytoplasm but then the equilibrium 
creatine kinase transfers (by a mechanism of facilitated 
diffusion of high-energy phosphate bonds) a significant 
proportion of the energy through the cytoplasm as a flux of 
phosphocreatine (spatial energy buffering - maintaining 
local ATP/ADP ratios). This concept is also entirely 
based on the consideration of equilibrium creatine kinase 
in homogeneous medium in one or several cellular com- 
partments, and therefore it also preserves the energy store 
function (temporary buffering) for phosphocreatine. A 
combination of facilitated diffusion of high-energy phos- 
phate bonds in the cytoplasm with the energy store func- 
tion confers on the creatine kinase system the property of 
metabolic apacity [19,20]. This aspect of the function of 
the creatine kinase system was recently analysed in detail 
by Sweeney [20]. The main advantage of this system is 
that is allows very rapid but short-burst energy use at the 
extended low rate of energy production [20]. Metabolic 
capacity of the creatine kinase system also allows equal 
distribution of energy inside cells even if its production is 
localized (mitochondrial c ustering around capillaries [21 ]). 
This seems to be the most satisfying explanation for the 
energetics of fast skeletal muscles with their mainly gly- 
colytic energy production and oxygen debt phenomenon. 
This theory explains the localization of CK isoenzymes in 
cellular structures by the necessity of creating equilibrium 
systems to maintain constant ATP/ADP ratios locally 
[18,20]. However, a very interesting biological phe- 
nomenon - a decrease in total cellular creatine kinase 
activity and total creatine content with elevation of total 
energy demand (as seen from comparison of fast, slow and 
cardiac muscle) [2,3,13-15] when one might expect an 
increase of capacity - still awaits its explanation within 
the framework of this theory. Also, this high capacity 
system, delaying the response of mitochondria to rapid 
increase in energy demand, temporarily uncouples energy 
production from its utilization - a property not very com- 
patible with high rates of energy utilization and fast work 
transitions as occurs in the heart. The explanation is most 
probably that in these cells, the capacity of the CK system 
is decreased but this is compensated for by creation of new 
systems of higher efficiency of regulation - coupled crea- 
tine kinases with the new quality of strong metabolic 
control. In this work we wish to emphasize this 'new' 
function of the CK system. 
2.3. Energy transfer and metabolic ontrol system 
The third concept of the physiological role of the 
creatine kinase system has been developed for more than 
40 years, starting with the pioneering works of Bessmann 
et al. (see Refs. [2,3,22,23] for reviews). It considers, in 
addition to facilitated energy transport by equilibrium crea- 
tine kinase in the cytoplasmic ompartment, direct func- 
tional coupling of MiCK with oxidative phosphorylation 
via adenine nucleotide translocase in mitochondria nd 
MM creatine kinase with MgATPases in myofibrils and on 
cellular membranes [2,3,22,23]. This is the concept of a 
phosphocreatine 'shuttle' [22] or 'circuit' [2,3] which is 
based on the compartmentation f creatine kinase isoen- 
zymes and adenine nucleotides in the muscle and brain 
cells. Biochemical and physiological evidence for these 
coupled systems is abundant and has been reviewed exten- 
sively [2,3,22,23,25,26,31]; here we analyse the meaning 
of this system for the regulation of cell function. 
If energy demand is increased and energy is used 
permanently in contraction cycles, a more direct and effi- 
cient way than the capacity system for the control of 
energy production and supply in response to a rapid in- 
crease in workload can be achieved simply by using the 
benefits of organization. Mitochondria in these cells be- 
come increasingly numerous and in heart cells they occupy 
up to 30-40% of the cell volume [24]. Increased energy 
demand in slow skeletal muscles or its permanent use in 
cardiac muscle requires fine regulation of its production 
and effective intracellular transfer, and most probably the 
creatine kinase systems were developed uring evolution 
both in mitochondria nd in myofibrils as well as at the 
cellular membranes to fulfil such requirements [2,3,22,23]. 
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While the total activity of creatine kinase decreases in the 
following order: fast skeletal - slow skeletal - cardiac 
muscle, the activity of mitochondrial creatine kinase in- 
creases in the same order and its share reaches 30-40% of 
total enzyme activity in the cardiac muscle: these two 
parameters of the creatine kinase system are inversely 
related to each other [13-15]. The mitochondrial creatine 
kinase isoenzyme is located at the outer surface of the 
inner mitochondrial membrane all along the cristae mem- 
brane and is mostly bound to the cardiolipin domain which 
surrounds the adenine nucleotide translocase [23,25]. It 
may also form complexes with porin pores in the outer 
mitochondrial membrane [2]. These structural complexes 
are located between the cytoplasm and mitochondrial inner 
membrane-matrix space where oxidative phosphorylation 
takes place. Therefore, they are in fact in position to 
dictate the course of events and to control local ADP and 
ATP concentrations in the intermembrane space of mito- 
chondria according to the mechanism of functional cou- 
pling, leaving little place for the global use of Michaelis- 
Menten kinetics and of calculated average cytoplasmic 
ADP concentration for explanation of the regulation of 
respiration and energy fluxes in general. The phenomenon 
of functional coupling has been described in multiple 
investigations (reviewed in Ref. [23]) and means 
substract-product, or metabolic channelling between 
translocase and MiCK due to their very close spatial 
proximity: translocase provides ATP from the matrix to 
the microenvironment of MiCK and takes back the ADP 
produced, in the presence of creatine, simultaneously with 
phosphocreatine. This ADP is in turn taken up by translo- 
case back into the matrix for rephosphorylation to start the 
new cycle. This coupled cycle is repeated many times and 
increases the turnover of adenine nucleotides, ending up in 
production of large amounts of phosphocreatine with a 
PCr/O ratio close to 3 [15,26]. In this very precisely 
organized system, the maximal activity of mitochondrial 
creatine kinase is equal to the rate of ATP production and 
translocation, and thus, to the total energy flux [15,23,26]. 
This means that all molecules of creatine kinase work hard 
and in one direction, leaving no place for a relaxed equilib- 
rium state; however, as a result of this fine organization 
the work is done very effectively, using a limited amount 
of enzymes at the right place. If we look from the cyto- 
plasmic side, the entry of even a very small amount of 
ADP into mitochondria s enough for acceleration of respi- 
ration, since the functionally coupled system is in fact a 
powerful amplifier for the regulatory action of ADP. Re- 
cent studies have revealed that this may be the most 
important property of coupled MiCK, since the outer mito- 
chondrial membrane porin channels [27] appear to have a 
low permeability for ADP in cells in vivo, in contrast o 
what is known for isolated mitochondria in vitro [28,29]. 
Indeed, this kind of specifically restricted ADP diffusion 
can be easily and directly shown in permeabilized car- 
diomyocytes or skinned muscle fibers, as demonstrated in 
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Fig. 1. The problems with regulation of respiration in cardiac cells in 
vivo: in contrast o isolated mitochondria (MT) which are rapidly acti- 
vated when the ADP concentration i the medium increases (apparent 
K m 17 /xM), in skinned cardiomyocytes (CM) or cardiac fibers (SF) 
without creatine (w/o  Cr) the respiration rate increases very slowly with 
elevation of ADP concentration and almost millimolar concentration of
ADP is needed for maximal activation of respiration (apparent K m 
around 300 /~M). In the presence of 25 mM creatine, when mitochondrial 
creatine kinase which is attached to the outer surface of the inner 
mitochondrial membrane produces ADP and channels it directly to 
translocase, the apparent K m for ADP is decreased to 40-70 /xM and 
only a small amount of ADP is needed to activate the coupled reactions 
in which adenine nucleotide turnover is increased by almost an order of 
magnitude. For example, to reach a respiration rate of 40 ngatom O/min 
per mg cell protein, in the case of CM without creatine, the ADP 
concentration should attain a value of 400/zM, but in the presence of 25 
mM creatine the range of necessary ADP concentrations is decreased to 
50-60 /xM (see dashed lines and arrows). This amplifying effect of 
coupled creatine kinase reaction on ADP regulation of cellular respiration 
in vivo is lost if creatine kinase is detached from the membrane in 125 
mM KCI solution (SF KC1 + Cr). (From Ref. [29] with permission.) 
Fig. 1. In contrast o isolated mitochondria, the apparent 
K m for ADP in regulation of respiration in permeabilized 
cells is more than an order of magnitude greater and equal 
to 300-400 /xM, but is decreased to 40-70 /xM if the 
creatine kinase reaction is activated and ADP produced in 
the intermembrane space in the coupled reactions; this 
means that high rates of respiration are maintained at low 
ADP concentrations, in spite of the low permeability of the 
outer membrane for this substrate in vivo - this is the 
amplification effect of the MiCK reaction on ADP regula- 
tion of respiration. Remarkably, and this is very important, 
detachment of the enzyme from the mitochondrial mem- 
brane results in complete loss of this kind of control 
[30,31] in spite of the enzyme remaining in the intermem- 
brane space - the direct metabolic hannelling, and there- 
fore functional coupling, is lost (Fig. 1). This shows that 
interaction between translocase and creatine kinase is in- 
deed based on the direct channelling of ATP and ADP 
between their binding (active) sites and not on the accumu- 
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lation of these substrates in the intermembrane space, 
which, however, may influence the reaction especially if 
the outer mitochondrial membrane permeability is limited 
[28]. Additionally, in cells in vivo the intermembrane 
space could be very much reduced as compared to in vivo 
conditions, and the outer membrane may be in continuous 
contact with the inner membrane [23,27]. 
Symmetrical reaction in another direction - local ATP 
resynthesis-  occurs in all energy-consuming systems 
catalysed by coupled MM-CK [23,32]. For contraction, the 
rate of ADP removal is essential, since it is an active 
component of the contraction cycle; its dissociation from 
myosin heads is related to the detachment of crossbridges 
and, if it accumulates in myofibrils, it slows down the 
process of crossbridge detachment, decreasing the rate of 
sliding of crossbridge-myosin heads - along the thin fila- 
ments [33,34] and thus the rate of force development, 
finally resulting in elevation of resting tension. Rapid 
removal of this ADP is the task of MM-CK localised in 
myofibrils in M-line and inside the I-band of sarcomeres. 
This is most probably not an equilibrium but an almost 
unidirectional steady-state process due to the favourable 
kinetic properties of MM-CK, and also occurs inside the 
myofibrillar compartment due to some kind of metabolic 
channelling [32]. Interestingly, the removal of ADP from 
crossbridges may to some extent be effectively performed 
by the glycolytic complex located in the 1-band [35,36]. 
Transgenic animal studies by using a series of mouse 
mutants with subnormal MM-CK expression confirmed 
that the ability of muscles to perform burst activity corre- 
lates with the level of MM-CK expression [37,38]. In these 
studies one new and interesting observation was made: 
when enzyme activity was decreased to 34% of normal, 
phosphorus NMR spectroscopy failed to show any flux in 
the CK system, but phosphocreatine was consumed in 
contractions [37,38]. Most probably, this directly shows 
that structurally bound creatine kinases in myofibrils and 
subcellular membranes (up to 30% of total) are function- 
ally connected to ATP pools in local microcompartments 
which may be NMR invisible due to interaction with 
proteins. A similar conclusion was drawn by Suzuki et al. 
who discovered a fraction of ATP with a long (14 s) T 1, 
probably due to interaction with proteins in rat heart, 
which represented about 30% of the total ATP content 
[39]. These conclusions are in good concord with the 
recent interpretation of these phenomena by Wallimann 
[40]. 
Thus, in addition to the metabolic apacity system - 
equilibrium creatine kinase in cytoplasm - we have the 
coupled creatine kinase isoenzymes functioning in steady 
state, via a mechanism of functional coupling (metabolic 
channelling), but in different directions depending on lo- 
calization. Metabolic channelling is very often related to 
the existence of microcompartments, as illustrated by crea- 
tine kinase functioning in myofibrils and probably in mito- 
chondria [23]. Moreover, one of the advantages (besides 
decreasing the transient ime of consecutive reactions and 
achieving the goals by using small numbers of enzymes) 
of the systems of metabolic channelling is that it has 
significantly increased flux control properties. Metabolic 
capacity systems are built to slow down and extend in time 
the metabolic response to load [18-20]. In the case of high 
and permanent fluctuation of energy demand this is not a 
useful property for rapid activation of mitochondrial en- 
ergy production. Modem theories of metabolic control 
analysis describe the control of fluxes quantitatively by 
flux control coefficients, and one of its basic theorems 
states that the sum of control coefficients does not exceed 
1 in homogeneous systems ([41], see Appendix). Kholo- 
denko et al. have developed this theory further, showing 
that in the systems of metabolic hannelling the sum of 
flux control coefficients ignificantly exceeds l [42-45], 
and we may conclude that such systems are controlled 
much more effectively than simple, homogeneous 
metabolic apacity systems. This means that the coupled 
creatine kinase systems acquire a new property - that of 
effective metabolic ontrol, already illustrated in Fig. 1. 
Aliev and Saks have developed a mathematical model of 
coupled creatine kinase reaction in mitochondria based on 
the probability approach ([46,47], see Appendix). Fig. 2 
reproduces one of these interesting results: in the model of 
the fully coupled creatine kinase reaction its activity was 
taken to be inhibited by 1%, and that decreased the rate of 
coupled oxidative phosphorylation by more than 8% as a 
result of decreased turnover of adenine nucleotides at very 
low ATP concentration, when the 'uncoupled' creatine 
kinase reaction is practically impossible [48]. This effect is 
consistent with the results shown in Fig. 1 which directly 
demonstrate increased turnover (about 5-8 times) of ATP- 
ADP in mitochondria by functionally coupled CK reaction. 
With elevation of the ATP concentration this flux control 
coefficient decreases but remains above 1 (Fig. 2). 
This means that in fully coupled systems the flux 
control coefficient may have a value higher than 8 and 
thus exceeds the value of 1 of homogeneous systems very 
significantly. 
3. Conclusions 
It is an interesting and even entertaining thought hat all 
three concepts described are true, depending on what we 
want to know about creatine kinases. The first one may 
still be completely sufficient o explain the cell metabolism 
for the period of prenatal development when one observes 
the appearance of soluble non-coupled creatine kinases, 
first B-type that later is switched in muscles to M-type 
subunits [5]. Mitochondrial creatine kinase coded by two 
separate genes in mammalian hearts appears only during 
the perinatal period in parallel with cell maturation when a 
several-fold increase in workload takes place, obviously to 
match the requirements for increased energy fluxes and 
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Fig. 2. One of the results of mathematical modelling of coupled creatine 
kinase reaction in heart mitochondria performed by Aliev and Saks 
[46,48]. The mathematical model is based on the probability approach and 
on the assumption of direct transfer of ATP and ADP molecules between 
mitochondrial creatine kinase and translocase, as shown by the scheme in 
the upper right corner (for further explanations see Appendix). Flux 
control coefficient: calculated change in coupled creatine kinase-oxidative 
phosphorylation (OP) reactions when 1% of creatine kinase is taken to be 
inactivated. Creatine concentration was assumed to be 25 mM and ATP 
concentration change as shown. At high ATP concentration the flux 
control coefficient exceeds l and when the ATP concentration i the 
medium decreases and approaches zero, the flux control coefficient 
approaches values exceeding 8! [48]. This is explained by high turnover 
of ATP and ADP in coupled reactions (see Fig. 1). The dependence of 
this parameter on ATP concentration is explained by the fact that the 
lower the ATP concentration, the lower the rate of its use in 'non-cou- 
pled' CK reaction and the higher the share of ADP supply in coupled CK 
reaction [48]. Of course, at zero ATP even coupled reactions top. (From 
Ref. [48] with permission.) 
their fine control [49]. For fast skeletal muscle, which 
contains only a small amount of mitochondria and a very 
large amount of soluble cytoplasmic reatine kinase, the 
metabolic apacity theory for creatine kinase may be a 
satisfying explanation. In mature mammalian hearts, slow 
twitch skeletal muscle and most probably in the brain, the 
metabolic capacity theory, however, is insufficient, be- 
cause it gives only one, cytoplasmic part of the story. In 
these and many other tissues [2,23] coupled systems with 
metabolic ontrol properties hould be taken into consider- 
ation. In addition to knowledge of the system, this may be 
a very useful concept in explaining many important phe- 
nomena. For example, recently the Schultheiss group in 
Germany obtained good evidence for the contribution by 
the destruction of the mitochondrial coupled creatine ki- 
nase system to acute ischemic heart failure [50]. Similar 
findings were made for cardiomyopathy [51]. This may 
lead to an important conclusion that only minor destruction 
of fine structural organization may lead to severe pathol- 
ogy of the cell. 
Thus, all three functions of the creatine kinase system 
are integrated in cells and cannot easily be dissected from 
each other. The temporary energy buffering role of this 
system was understood since the studies of Cain and 
Davies [8]. The metabolic apacity function was deduced 
from quantitative analysis of the equilibrium creatine ki- 
nase reaction first by Nagle in 1970 [52] and significantly 
later by Meyer and Sweeney [18-20]. The third approach 
takes into account the highly organized structure of the cell 
interior and the existence of multiple compartments and 
direct metabolic hannelling in the cells. This role of the 
creatine kinase system in energy transfer and metabolic 
control has been confirmed by numerous biochemical and 
physiological studies of coupled creatine kinase systems in 
vitro reviewed in [2,3,22,23,29,32]. Further, significant 
functional and structural changes in muscles induced in 
energy-deficient states due to decreased level of phospho- 
creatine and creatine in experiments with its analogs [23], 
due to alterations in creatine kinase isoenzyme xpression 
in pathologies uch as dilated cardiomyopathy [51] or in 
experiments with 'knock-out' of these isoenzymes in 
transgenic animals [37,38,40], are consistent with this con- 
cept of the central role of the creatine kinase system in 
integration and regulation of energy fluxes between differ- 
ent cellular compartments. 
3.1. Further problems 
However, in addition to these achievements in explain- 
ing different aspects of functioning of creatine kinases, 
these new developments present us with new and even 
greater problems to explain. One of these concerns the 
question: for what reason is the apparent K m for ADP in 
regulation of oxidative phosphorylation in vivo so high in 
several types of cells including heart, red muscle and liver? 
This high apparent K m is characteristic for exogenous 
ADP, and maybe shows that there might be intracellular 
systems for metabolic feedback signal transduction by a 
mechanism of vectorial ligand conduction, proposed by 
Mitchell [53], due to organized cytoplasmic structures in 
these cells, including binding of both creatine kinase and 
glycolytic enzymes to the cytoskeleton ([28,55]; for re- 
views see Refs. [23,29]). Perhaps these organised systems 
transfer internal ADP very effectively, thus almost exclud- 
ing the use of exogenous ADP and thus resulting in high 
apparent K m values for this substrate, if it is exogenous. 
Or, is the outer membrane closed for the adenine nu- 
cleotides which are actively turning over inside the mito- 
chondria nd related to cytoplasmic systems via phospho- 
creatine and creatine? What is the structure that controls 
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the outer membrane? Is it connected, and if so how, to the 
cytoskeleton, as has been proposed [29]? How is control of 
respiration by creatine kinase modified by other possible 
regulatory systems, let us say, calcium? A very important 
question is the interaction between creatine kinase and 
adenylate kinase systems in the cells and possible 'take- 
over' of metabolic energy transfer and control function by 
the latter if the creatine kinase system is altered in patho- 
logical states or in experiments with transgenic animals 
[40,54]. More generally, it is important o understand the 
direct functional interaction between various kinases chan- 
nelling energy between mitochondria and different 
metabolic pathways (hexokinase, creatine kinase, adeny- 
late kinase, nucleoside diphosphokinase) [55]. Further- 
more, what kind of changes in the creatine kinase MM 
isoenzyme molecule make it able to bind to myofibrils and 
build up the functionally coupled system during perinatal 
maturation? etc. All these questions have an even bigger 
impact on cellular physiology than that of the role of 
creatine kinase systems, since they concern the general 
questions of structural organization of cell energy 
metabolism and its importance for regulation of metabolic 
fluxes - all these problems may be referred to as struc- 
tural bioenergetics of the cell. Thus, instead of taking the 
question of the physiological role of creatine kinase in the 
cell as being resolved, we have much more work to do and 
many new data to consider. 
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Appendix A 
1. Aerobic processes of phosphocreatine synthesis in 
mitochondria, based on functional coupling between crea- 
fine kinase and adenine nucleotide translocase, can be 
quantitatively described by a mathematical model which 
gives a good fit with experimental data [46-48]. This 
model includes: 
1. The kinetic equation of the creatine kinase reaction 
based on its mechanism (quasi-equilibrium random 
binding Bi-Bi type) for description of interaction of the 
enzyme with its substrates in the surrounding medium; 
2. A system of equations based on the probablity ap- 
proach, for a description of the interaction of enzyme 
with mitochondrial ATP by direct transfer of ATP from 
translocase to creatine kinase and ADP back from 
creatine kinase to translocase (functional coupling) re- 
sulting in the synthesis of phosphocreatine in mito- 
chondria and increased turnover of adenine nucleotides 
in mitochondria. 
These equations and their use have been described in 
previous publications [46-48]. In the present work they 
were used to calculate the flux control coefficient for 
coupled creatine kinase. 
2. In metabolic control analysis (see Ref. [41] for a 
detailed description), regulation of the steady-state rate of 
the overall reaction, or flux, J, in a metabolic system 
consisting of many consecutive reactions is considered to 
result from regulatory action at each step (reaction) of the 
process. Participation of each step in flux regulation is 
quantitatively expressed by the flux control coefficient 
calculated as a relative change of flux, d J/J, resulting 
from the relative change of the enzyme activity, e, at that 
step, de/e ,  when all other parameters of the system are 
not changed. Thus, the flux control coefficient, C, is [41]: 
C = (din J ) / (d ln  e) 
It has been shown by Kacser and Burns [56] and Heinrich 
and Rappaport [57] that, in a homogeneous system of 
enzymatic reactions, the sum of flux control coefficients of 
all enzymes in a flux J pathway must always equal 1 (the 
flux control summation theorem). 
The values of the flux control coefficient for mitochon- 
drial coupled creatine kinase reaction in regulation of the 
steady-state rate of oxidative phosphorylation (see Fig. 2) 
were calculated in the following way. 
For each ATP concentration, the steady-state rates of 
coupled reactions of oxidative phosphorylation-phospho- 
creatine production (Vcp) were calculated. The calculation 
were then repeated for a system with partially inhibited 
creatine kinase. Noncompetitive inhibition was achieved 
by multiplying the probabilities of formation of all intrin- 
sic creatine kinase forms (E, E.  Cr, E.  ATP and E. Cr. 
ATP; see Ref. [46]) by the coefficient of residual activity 
which is 0.99 for 1% inhibition, 0.98 for 2% inhibition, 
etc. The intrinsic forms are those formed by interaction of 
the enzyme with substrates in the medium. This procedure 
mimics the inhibition-caused decrease in the population of 
CK forms available for subsequent activation in the cou- 
pled reaction. Thereafter the model performs the calcula- 
tions for creatine kinase activities in the coupled reactions. 
In these calculations the participants are the full population 
of translocase molecules and decreased (from given inhibi- 
tion) population of creatine kinase molecules. Finally, the 
model calculates the flux control coefficient for each ATP 
concentration as: 
C = (dVcp/Vcp) / (dEck /Eck)  
where dEck/Eck is the relative change of creatine kinase 
activity, and dVop/Vcp (=d J/ J)  is the corresponding 
change in the steady-state rate of coupled reactions of 
oxidative phosphorylation-phosphocreatine production. 
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